Back

Select your region

Corporate

europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Schedule a cord blood consultation

Make an appointment

Contact us today!

Want to learn more about our services? Complete the form below and we will contact you as soon as possible to provide you with all the information you need and answer your questions.

    We kindly inform you that the personal data provided in the form will be processed by Polski Bank Komórek Macierzystych Sp. z o.o. ("PBKM") with its registered office in Warsaw, Al. Jana Pawła II 29 for telephone contact in connection with the provision of information on the service.

    Summary of patients treated

    Stem Cells
    Therapies

    Stem Cells Therapies

    The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).

    FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.

    Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.

    Check the full list of patients who received stem cell therapy derived from FamiCord labs.

    List last update: 06.2026

    List of patients who received stem cells from FamiCord Group laboratories

    List of patients who received stem cells from FamiCord Group laboratories
    Lp. Source Source type Diagnosis Medical field Year of application Therapy Country Age of recipient
    7901 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 68
    7902 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 63
    7903 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 57
    7904 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 68
    7905 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 56
    7906 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 61
    7907 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 55
    7908 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 64
    7909 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 64
    7910 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 52
    7911 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 55
    7912 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 67
    7913 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 49
    7914 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 56
    7915 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 47
    7916 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 53
    7917 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 58
    7918 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 49
    7919 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 69
    7920 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 61
    7921 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 54
    7922 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 65
    7923 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 48
    7924 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 60
    7925 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 56
    7926 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 50
    7927 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 73
    7928 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 47
    7929 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 67
    7930 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 62
    7931 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 61
    7932 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 68
    7933 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 65
    7934 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 15
    7935 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 52
    7936 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 20
    7937 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 60
    7938 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 9
    7939 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 61
    7940 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 63
    7941 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 15
    7942 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 37
    7943 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 59
    7944 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 62
    7945 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 58
    7946 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 69
    7947 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 66
    7948 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Germany 67
    7949 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Germany 57
    7950 Apheresis Allogeneic Myelodysplastic Syndrome – Rcmd Hematology 2016 Standard Therapy Poland 32
    7951 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb Hematology 2016 Standard Therapy Poland 56
    7952 Apheresis Allogeneic Myelofibrosis Hematology 2016 Standard Therapy Poland 72
    7953 Apheresis Allogeneic Myelofibrosis Hematology 2016 Standard Therapy Poland 66
    7954 Apheresis Allogeneic Myelofibrosis Hematology 2016 Standard Therapy Poland 67
    7955 Apheresis Allogeneic Myeloma Multiplex Hematology 2016 Standard Therapy Poland 63
    7956 Apheresis Allogeneic Myeloma Multiplex Hematology 2016 Standard Therapy Poland 51
    7957 Apheresis Allogeneic Myeloma Multiplex Hematology 2016 Standard Therapy Poland 38
    7958 Apheresis Allogeneic Myeloproliferative Syndrome Hematology 2016 Standard Therapy Poland 52
    7959 Apheresis Allogeneic Myeloproliferative Syndrome Hematology 2016 Standard Therapy Germany 63
    7960 Apheresis Autologous Neuroblastoma Hematology 2016 Standard Therapy Germany 5
    7961 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 45
    7962 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 70
    7963 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 43
    7964 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 69
    7965 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 28
    7966 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 1
    7967 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 30
    7968 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 71
    7969 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 58
    7970 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 17
    7971 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 59
    7972 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 58
    7973 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 55
    7974 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 44
    7975 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 38
    7976 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 58
    7977 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 32
    7978 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 39
    7979 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 61
    7980 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 73
    7981 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 27
    7982 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 65
    7983 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 61
    7984 Apheresis Allogeneic Plasma Cell Disorder Hematology 2016 Standard Therapy Poland 47
    7985 Apheresis Autologous Plasmacytoma Hematology 2016 Standard Therapy Germany 58
    7986 Apheresis Autologous Plasmacytoma Hematology 2016 Standard Therapy Germany 68
    7987 Apheresis Autologous Plasmacytoma Hematology 2016 Standard Therapy Germany 48
    7988 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2016 Standard Therapy Germany 62
    7989 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2016 Standard Therapy Germany 51
    7990 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2016 Standard Therapy Germany 62
    7991 Apheresis Allogeneic Primary Immunodeficiency Hematology 2016 Standard Therapy Poland 5
    7992 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Poland 50
    7993 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Poland 67
    7994 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Poland 67
    7995 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Germany 56
    7996 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Germany 58
    7997 Apheresis Allogeneic Refractory Anemia With Excess Blasts Hematology 2016 Standard Therapy Poland 62
    7998 Apheresis Allogeneic Severe Aplastic Anemia / Amyloidosis Hematology 2016 Standard Therapy Poland 45
    7999 Apheresis Allogeneic Secondary Acute Myeloid Leukemia At Myeloproliferative Syndrome Hematology 2016 Standard Therapy Germany 28
    8000 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2016 Standard Therapy Poland 18